share_log
  • 要聞
  • Scilex控股報告顯示，2024年第三季度ZTlido的淨銷售額在1100萬至1300萬美元的區間內，同比增長9%至29%；總產品淨銷售額預計爲1200萬至1400萬美元，同比增長19%至39%。

Scilex Holding Reports Preliminary Q3 2024 Net Sales Of ZTlido In Range Of $11M-$13M, Up 9%-29% YoY; Total Product Net Sales Estimated At $12M-$14M, Up 19%-39% YoY

Scilex Holding Reports Preliminary Q3 2024 Net Sales Of ZTlido In Range Of $11M-$13M, Up 9%-29% YoY; Total Product Net Sales Estimated At $12M-$14M, Up 19%-39% YoY

Scilex控股報告顯示，2024年第三季度ZTlido的淨銷售額在1100萬至1300萬美元的區間內，同比增長9%至29%；總產品淨銷售額預計爲1200萬至1400萬美元，同比增長19%至39%。
Benzinga ·  10/08 14:00
  • ZTlido net sales for the quarter ended September 30, 2024 were in the range of $11.0 million to $13.0 million, compared to $10.1 million for the same period last year, representing growth in the range of approximately 9% to 29%.
  • Total product net sales for the quarter ended September 30, 2024 were in the range of $12.0 million to $14.0 million, compared to $10.1 million for the same period last year, representing growth in the range of approximately 19% to 39%.
  • 2024年9月30日結束的ZTlido淨銷售額在1100萬美元到1300萬美元的區間內，與去年同期的1010萬美元相比，增幅約爲9%至29%。
  • 2024年9月30日結束的總產品淨銷售額在1200萬美元到1400萬美元的區間內，與去年同期的1010萬美元相比，增幅約爲19%至39%。

PALO ALTO, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (NASDAQ:SCLX, "Scilex" or the "Company"))))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today provided certain preliminary unaudited financial results for the quarter ended September 30, 2024.

加利福尼亞州帕洛阿爾託，2024年10月8日(環球新聞通訊社) -- Scilex控股公司（納斯達克股票代碼:SCLX, "Scilex"或"公司"）是一家創新的營收公司，專注於收購、開發和商業化非阿片類疼痛管理產品，用於治療急性和慢性疼痛，今天提供了2024年9月30日結束的季度某些初步未經審計的財務業績。

The Company estimates that:

公司估計:

  • ZTlido net sales for the quarter ended September 30, 2024 were in the range of $11.0 million to $13.0 million, compared to $10.1 million for the same period last year, representing growth in the range of approximately 9% to 29%.
  • Total product net sales for the quarter ended September 30, 2024 were in the range of $12.0 million to $14.0 million, compared to $10.1 million for the same period last year, representing growth in the range of approximately 19% to 39%.
  • 2024年9月30日結束的ZTlido淨銷售額在1100萬美元到1300萬美元的區間內，與去年同期的1010萬美元相比，增幅約爲9%至29%。
  • 2024年9月30日結束的總產品淨銷售額在1200萬美元到1400萬美元的區間內，與去年同期的1010萬美元相比，增幅約爲19%至39%。
声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間